scholarly journals Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome

2008 ◽  
Vol 198 (2) ◽  
pp. 226-233 ◽  
Author(s):  
Irving Nachamkin ◽  
Sean V. Shadomy ◽  
Anthony P. Moran ◽  
Nancy Cox ◽  
Collette Fitzgerald ◽  
...  
Keyword(s):  
Influenza Vaccines ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Antibody Induction ◽  
Guillain Barré

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season

2014 ◽  
Vol 23 (5) ◽  
pp. 548-553 ◽  
Author(s):  
Alison Tse Kawai ◽  
Lingling Li ◽  
Martin Kulldorff ◽  
Claudia Vellozzi ◽  
Eric Weintraub ◽  
...  
Keyword(s):  
Influenza Vaccines ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome

2004 ◽  
Vol 114 (11) ◽  
pp. 1659-1665 ◽  
Author(s):  
Peggy C.R. Godschalk ◽  
Astrid P. Heikema ◽  
Michel Gilbert ◽  
Tomoko Komagamine ◽  
C. Wim Ang ◽  
...  
Keyword(s):  
Campylobacter Jejuni ◽  
Crucial Role ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Antibody Induction ◽  
Guillain Barré

scholarly journals No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies

2011 ◽  
Vol 6 (3) ◽  
pp. 159-166 ◽  
Author(s):  
David J. Wang ◽  
David A. Boltz ◽  
Janet McElhaney ◽  
Jonathan A. McCullers ◽  
Richard J. Webby ◽  
...  
Keyword(s):  
Influenza Vaccines ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups

PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0246540
Author(s):  
Tazio Vanni ◽  
Beatriz da Costa Thomé ◽  
Mayra Martho Moura de Oliveira ◽  
Vera Lúcia Gattás ◽  
Maria da Graça Salomão ◽  
...  
Keyword(s):  
Adverse Events ◽  
Pregnant Women ◽  
Prospective Cohort ◽  
Healthcare Workers ◽  
Vaccine Safety ◽  
Median Number ◽  
Influenza Vaccines ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

Introduction Active pharmacovigilance studies are pivotal to better characterize vaccine safety. Methods These are multicenter prospective cohort studies to evaluate the safety of the 2017 and 2018 seasonal trivalent influenza vaccines (TIVs) manufactured by Instituto Butantan, by means of active pharmacovigilance practices. Elderly, children, healthcare workers, pregnant women, and women in the puerperium period were invited to participate in the study during the 2017 and 2018 Brazilian national seasonal influenza vaccination campaigns. Following immunization, participants were observed for 30 minutes and they received a participant card to register adverse events information. All safety information registered were checked at a clinical site visit 14 days after immunization and by a telephone contact 42 days after immunization for unsolicited Adverse Events (AE) and Guillain-Barré Syndrome (GBS). Results A total of 942 volunteers participated in the two studies: 305 elderly, 109 children, 108 pregnant women, 32 women in the postpartum period, and 388 health workers. Overall, the median number of AR per participant ranged from 1 to 4. The lowest median number of AR per participant was observed among healthcare workers (1 AR per participant) and the highest among pregnant women (4 AR per participant). Overall, local pain (46.6%) was the most frequent solicited local AR. The most frequent systemic ARs were: headache (22.5%) followed by fatigue (16.0%), and malaise (11.0%). The majority of solicited ARs (96%) were mild, Grades 1 or 2), only 3% were Grade 3, and 1% was Grade 4. No serious AEs, including Guillain-Barré Syndrome, were reported up to 42 days postvaccination. Conclusion The results from the two studies confirmed that the 2017 and 2018 seasonal trivalent influenza vaccines produced by Instituto Butantan were safe and that active pharmacovigilance studies should be considered, when it is feasible, as an important initiative to monitor vaccine safety in the post-marketing period.

Guillain-Barré syndrome and influenza vaccines: A meta-analysis

Vaccine ◽  
2015 ◽  
Vol 33 (31) ◽  
pp. 3773-3778 ◽  
Author(s):  
L.H. Martín Arias ◽  
R. Sanz ◽  
M. Sáinz ◽  
C. Treceño ◽  
A. Carvajal
Keyword(s):  
Meta Analysis ◽  
Influenza Vaccines ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Guillain Barré
Sign in / Sign up

Export Citation Format

Share Document